The group of disorders first described as collagen diseases by Klemperer et al. (1942) was soon followed by the discovery of that autoimmune curiosity, the LE phenomenon (Hargreaves et al. 1948 ) and auto-antibodies to collagen itself (reviewed by Furthmayr & Timpl 1976 ). However, it was the advances in understanding of the structure and polymorphic varieties of collagen (reviewed by Dr V C Duance, Department of Animal Husbandry, Bristol) which has permitted the logical identification of collagen's antigenic determinants.
It is now known that there are 18 different collagen chains composed of at least II distinct molecules; most of the work characterizing antigenic determinants has been obtained from studying type I collagen with a molecular form [od(l)h:x2. Types of antigenic determinant found in every collagen chain are helical, non-helical, sequential and procollagen. Antibodies to helical determinants only recognize the native molecules. This may be shown by pairing artificially-created hybrid molecules to involve all three alpha chains. Non-helical epitopes are located in the telopeptide region of the molecule and are conformationally independent. These antigenic determinants are found in both the amino-and carboxy-terminal telopeptides of each alpha chain. The sequential determinants sited in the helical region appear only in denatured molecules, like most of the larger cleavage peptides produced by cyanogen bromide. These antigenic determinants were demonstrated by haemagglutination inhibition technique. Determinants in the procollagen molecule are found on the amino and carboxy extension peptides. The amino determinant resides in the non-triple helical portion of the extension peptide. The locus of the carboxy determinant is not known, except that it exists as a conforniationally dependent determinant which is destroyed by mercapto-ethanol. No sequential antigenic determinants have yet been described on the collagen precursor molecule. The implication is that when screening clinical conditions, tests for antibodies to all these determinants should be devised.
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Dr M E Grant (Department of Biochemistry, Manchester) related how many of the chronic diseases in man are characterized by the accumulation of large quantities of collagen. In many instances, this accumulation arises as a consequence of increased collagen synthesis rather than decreased degradation. Studies on the control of collagen gene expression and the assembly of the collagen fibres are obviously relevant to an understanding of such conditions (Prockop et al. 1979) .
The application of recombinant DNA technology to this area of biochemistry indicates that collagen genes posses the most complex structure of any eukaryotic gene studied to date. Thus, the gene for one of the chains of type I collagen has been found to have the coding sequences (exons) spread out over approximately 40 kilobases and to be split by 49 intervening sequences (introns) of variable length (Ohkubo et al. 1981) . The primary RNA transcript undergoes several enzymic post-transcriptional modifications before the introns are spliced out to yield a functional mRNA. Translation of collagen mRNA in heterologous cell-free systems demonstrates that the messenger codes for precursor polypeptides (pre-pro-a chains) in which the hydrophobic N-terminal signal peptide plays a role in the directional discharge of nascent collagen peptides into the lumen of the endoplasmic reticulum. The polypeptides then undergo a series of enzymic post-translational modifications involving three hydroxylases and two glycosyltransferases. Assembly of the triple helix appears to be a prerequisite for normal secretion of soluble procollagen molecules, which subsequently undergo cleavage of their N-and Cterminal propeptides to give the collagen fibril monomer (Grant & Jackson 1976) . Spontaneous aggregation of monomers yields collagen fibrils which are stabilized by intermolecular covalent cross-links derived from hydroxyl lysine and/or lysine residues. The formation of these cross-links may be inhibited by lathyrogens or penicillamine (Levene 1978) . The significance of post-transcriptional and post-translational processing steps was discussed and the sites at which control of collagen synthesis might be achieved was indicated. Special reference was made to the post-translational faulty hydroxylation of proline which depends upon vitamin C. Deficiency of this vitamin produces a poor collagen which does not stand up to stress. Such defects in synthesis are probably the only true collagen diseases, while the experimental anticollagen arthritis may well reflect altered immune responses.
Since the I950s, it has been known that intradermal injection of Freund's complete adjuvant (small quantities of finely ground heatkilled Mycobacteria suspended in mineral oil) induced a delayed polyarthritis of characteristic pattern 9-17 days later. No response could be recorded if the skin of any other mammal, apart from the rat, was used or if incomplete Freund's adjuvant was substituted for the complete form. The presence of homologous tissue such as synovia was not required.
In 1977Trentham et al. showed that native type II collagen from the human, rat or chick, given with complete or incomplete Freund's adjuvant, provoked an autoimmune arthritis in 41% of 348 injected rats. Denatured type II collagen was not arthritogenic. This suggested that the intact helical region of the collagen molecule was necessary to induce arthritis. Dr K Morgan (Department of Rheumatology, Manchester) described his findings using this model following intradermal injection of rats with native bovine type II collagen. The collagen was emulsified again in either Freund's complete or incomplete adjuvant. It was not surprising that lesions were found not only in the joints of the limb but also in the tail discs and sometimes in the ears, as type II collagen is the predominant collagen component of cartilage. The internal organs were spared.
Although the collagen antibodies raised with bovine type II collagen reacted with the rat collagen, immunization could not be achieved with rat type II collagen. Using this model, Dr Morgan found that antibodies to native type II collagen were elevated before the clinical onset of arthritis and tended to be higher in the arthritic than non-arthritic rats (Morgan et al. 1980 , Clague et al. 1981 . Depletion of the third component of serum complement by cobra venom factor delayed the onset of arthritis, while preliminary histology showed an extensive polymorphonuclear leukocyte infiltration to be present in the lesions. The destruction of the articular cartilage in some of the rats with chronic arthritis let to ankylosis. It would be interesting to evaluate the responses of this arthritis to gold, chloraquine and penicillamine, to which the human 'collagen arthritides' are so susceptible. In principle-this rat model for joint damage after immunological injury could be valuable in human diseases.
Dr R B Clague, also of the Department of Rheumatology at Manchester, reviewed the early reports of antibody to different types of native or denatured collagen in patients with rheumatoid arthritis (Mestecky et al. 1979) . Recent studies have not confirmed the high incidence of antibodies found in earlier studies. Antibodies to native type II collagen have only been found in 3-5% of sera examined (Greenbury & Skingle 1979 , Beard et al. 1979 . It was suggested that a raised fibronectin level could have been responsible for 'false positive' haemagglutination, as this technique had been used to detect antibody. Fibronectin is a glycoprotein structurally similar to serum 'cold insoluble' globulins, and conventional antibodies to either cross-react. A major function offibronectin is thought to involve adhesion of cells to surfaces (Yameda 1978) , so antibodies to fibronectin or perhaps fibronectin alone may cause agglutination with the collagencoated red cells in the anticollagen antibody haemagglutination tests. Reports of collagen antibodies in such widely diverse conditions as emphysema, selective IgA deficiency and leprosy, may also be explained as false positives on a similar basis. It is now thought that antibodies against collagen in relapsing polychondritis, usually detected by immunofluorescence, now appear to be directed against the proteoglycan component of cartilage.
Dr Clague then discussed his modified solid phase radioimmune assay used to detect antibodies to collagen. The test had been modified to allow for nonspecific binding of immunoglobulins to be excluded. This test showed raised serum antibody levels to native type II collagen in 26 (13%) of 200 patients with rheumatoid arthritis, but not in other chronic inflammatory arthritides. There was a good correlation with the presence of these antibodies in the serum and their presence in synovial fluid. The antibodies did not seem to be associated with any particular clinical laboratory or radiological feature, whether there were no radiological changes or severe erosive disease. Eight cases in which collagen antibodies had been found had negative rheumatoid latex tests.
The great variability in the incidence of collagen antibodies detected by the different immunological techniques requires further studies on standardization. The significance of. collagen antibodies in man is not yet understood, though they may have a role in defining different subsets of patients with rheumatoid arthritis.
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Exocrine pancreatic disease!
A meeting was held which broke with tradition, as instead of a single paper by the new President of the Section, the inaugural address was followed by three other papers, all of which were related to the pathology of the exocrine pancreas. To begin with, the President, Dr R Finlayson, gave a most interesting and well-illustrated talk about reptilian, and more particularly, ophidian exocrine pancreatic disease. Many snakes have been examined from zoological collections in the UK and USA. About 40 years ago, Ratcliffe, in the USA, described carcinoma of the pancreas in a small number of snakes he had studied. Although pancreatic cancer is common in man, doubts have been expressed about its occurrence in reptiles. The lesions seen in exocrine pancreatic disease of snakes fall into three categories. They are either restricted to the ducts themselves, involve both ducts and parenchyma, or are almost purely parenchymal. Duct lesions are usually associated with bacterial or parasitic conditions. The parenchymatous lesions seen in snakes are usually infective granulomata, hyperplastic nodules or multiple small foci of acute acinar necrosis. It seems probable that what Ratcliffe described as carcinoma was in fact multiple nodular hyperplasia, which is almost certainly related to a captive environment and is possibly nutritional in origin. Dr Finlayson's talk was followed by a review of the structure and pathology of the pancreas of domestic animals by Dr E C Appleby, which was profusely illustrated with transparencies. There are many similarities with pancreatic disease of man. Atrophy of the pancreas sometimes occurs in dogs about eight months old, associated with a wasting disease. The cause in unknown. Acute necrotizing pancreatitis, with self digestion of the pancreas, occurs in dogs, as in man. There is speculation as to the cause of this disease, which also occurs in the horse and pig, and is usually fatal in two or three days. Amongst the domesticated animals, chronic interstitial pancreatitis is most often seen in the cat. It may be associated with ascending infection from the gut, or sometimes with obstruction of the duct by parasites. Pancreatic calculi are rare, but sometimes occur in the cow. So far as proliferative disease is concerned, nodular hyperplasia is common in domestic animals, especially the cat, but adenomas are rarely described. Malignant tumours of the exocrine pancreas are uncommon. They often metastasize to the surrounding abdominal organs and are not always easy to distinguish from biliary carcinoma. They are more common in cats and dogs than in herbivores. Carcinoma of the pancreatic region appears to be particularly common in bears! Dr D A Levison spoke about carcinoma of the pancreas, which is now more common in man than carcinoma of the stomach. The cause of
